ArticleBMC rheumatology2026
Self-reported depression on the Lupus Impact Tracker questionnaire (LIT) is associated with glucocorticoid use and fibromyalgia in systemic lupus erythematosus, according to RELESSER-PROS registry data.
Article in BMC rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo assess the prevalence and persistence of self-reported depression and its associated factors in patients with systemic lupus erythematosus (SLE), using a patient-reported outcome measure in a large, multicentre, prospective cohort.
methodsWe conducted a longitudinal analysis of patients enrolled in the RELESSER-PROS registry who responded to item 7 (“I was depressed”) of the Lupus Impact Tracker questionnaire (LITQ7) over five annual visits. Self-reported depression was defined as any response other than “none of the time.” Covariates assessed at each visit included: age, disease duration, SELENA-SLEDAI (S-SLEDAI), glucocorticoid (GC) use, SLICC/ACR Damage Index (SDI), fibromyalgia, Charlson index, BMI, smoking status, menopause, sedentary lifestyle, marital and employment status. Generalized estimating equation (GEE) models were used to examine longitudinal associations.
resultsOf 1463 patients (mean age 55 years; 90% female), 89.9% reported depressive symptoms at least once; 26.5% reported feeling depressed “most of the time” at all five visits. Patients with self-reported depression in LIT accumulated significantly more damage over time (p = 0.009). In multivariable analysis, fibromyalgia (OR 2.90; 95% CI: 1.58–5.33) and GC use (OR 1.85; 95% CI: 1.17–2.93) were independently associated with self-reported depression.
conclusionsSelf-reported depression is highly prevalent and often persistent among patients with SLE. Its association with potentially modifiable factors such as GC use and fibromyalgia highlights the value of integrating patient-reported outcomes such as LIT into longitudinal care, potentially contributing to improve emotional well-being.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.